CLARANOVA SE (CLA.PA)

FR0013426004 - Common Stock

1.734  -0.01 (-0.34%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLA. CLA was compared to 92 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.



4

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.
CLA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
In the past 5 years CLA always reported a positive cash flow from operatings.

1.2 Ratios

CLA's Return On Assets of -1.71% is on the low side compared to the rest of the industry. CLA is outperformed by 65.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 55.60%, CLA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLA is in line with the industry average of 11.55%.
The 3 year average ROIC (13.37%) for CLA is below the current ROIC(55.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.71%
ROE N/A
ROIC 55.6%
ROA(3y)-1.22%
ROA(5y)-5.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)13.37%
ROIC(5y)10.65%

1.3 Margins

With a Operating Margin value of 7.12%, CLA perfoms like the industry average, outperforming 50.62% of the companies in the same industry.
CLA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 27.33%, CLA is not doing good in the industry: 86.42% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CLA has remained more or less at the same level.
Industry RankSector Rank
OM 7.12%
PM (TTM) N/A
GM 27.33%
OM growth 3Y21.32%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.27%
GM growth 5Y0.82%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLA is creating value.
Compared to 1 year ago, CLA has less shares outstanding
The number of shares outstanding for CLA has been increased compared to 5 years ago.
CLA has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.79, we must say that CLA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.79, CLA is doing worse than 77.78% of the companies in the same industry.
CLA has a debt to FCF ratio of 5.92. This is a neutral value as CLA would need 5.92 years to pay back of all of its debts.
CLA has a Debt to FCF ratio of 5.92. This is comparable to the rest of the industry: CLA outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.92
Altman-Z 0.79
ROIC/WACC8.18
WACC6.8%

2.3 Liquidity

CLA has a Current Ratio of 0.58. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.58, CLA is not doing good in the industry: 95.06% of the companies in the same industry are doing better.
CLA has a Quick Ratio of 0.58. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Quick ratio (0.52) than 95.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.52

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.45% over the past year.
CLA shows a decrease in Revenue. In the last year, the revenue decreased by -2.84%.
The Revenue has been growing by 25.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.84%
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y7.41%
Revenue growth 5Y25.71%
Sales Q2Q%-4.35%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 410.87% yearly.
The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y4483.33%
EPS Next 2Y927.41%
EPS Next 3Y410.87%
EPS Next 5YN/A
Revenue Next Year-0.29%
Revenue Next 2Y2.71%
Revenue Next 3Y3.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 5.42, the valuation of CLA can be described as very cheap.
98.77% of the companies in the same industry are more expensive than CLA, based on the Price/Forward Earnings ratio.
CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.59.
Industry RankSector Rank
PE N/A
Fwd PE 5.42

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaply inside the industry as 95.06% of the companies are valued more expensively.
98.77% of the companies in the same industry are more expensive than CLA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.89
EV/EBITDA 3.23

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 410.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y927.41%
EPS Next 3Y410.87%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (7/26/2024, 7:00:00 PM)

1.734

-0.01 (-0.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap98.39M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.42
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.71%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 7.12%
PM (TTM) N/A
GM 27.33%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.58
Quick Ratio 0.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y4483.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y7.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y